After hours: January 10 at 6:15:26 PM EST Loading Chart for CRI ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Team Rudimentality created Bad Business and was heavily inspired by one of the best browser games around: Krunker.io If you want your character to stand out from the crowd, our Bad Business codes list ...

– Niktimvo™ (axatilimab-csfr) approved by U.S. FDA for treatment of chronic GVHD after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg – ...

Updated data that showed an ORR of 82% (27/33) and a CR/CRh rate of 48% (16/33) were presented at the 66 th ASH Annual Meeting.

? Launched Revuforj ® (revumenib) for treatment of R/R acute leukemia with a KMT2A translocation in adult and pediatric patients one year and older ? ? Niktimvotm (axatilimab-csfr) approved by ...